Hawthorne Effect is working with Abbott on the LIFE-BTK trial, which is evaluating the safety and effectiveness of the ESIPIRTTM Bioresorbable stent as a way to reduce leg pain and increase mobility in seniors with Peripheral Arterial Disease.
In this trial, Hawthorne Effect will be conducting home visits that will require assessment of the patient's affected limb, any wounds, and an ABI/TBI. These visits will also require Duplex Ultrasound. This is one of the many clinical trials we are supporting that allow Hawthorne Effect Heroes to be truly on the front lines of transformational, lifesaving clinical research. We are looking for Heroes to express interest in conducting home visits that will improve the quality of life for seniors.Learn More
Hawthorne Effect and Nobelpharma are pleased to announce their partnership with Lionheart21, an on-going phase 2, randomized, double-blind, placebo-controlled study of NPC-21 for kidney transplant recipients at high-risk of cytomegalovirus infection. It's the perfect match to advance medical therapy that can extend the life of a vital transplant organ.
We are actively seeking healthcare professionals with exceptional courage to help us conduct in-home patient follow-up visits for this landmark clinical trial. If you are a well-qualified professional with a work ethic that embraces attention to detail, and you can routinely devote yourself to the project, please consider joining our vast network of Heroes and sign up today.Learn More
Hawthorne Effect has been awarded the opportunity to collaborate with the NIH and investigational sites in Activ3/Operation Warp Speed to ensure post-discharge study patients complete their follow-up study blood draws. This is one of the many clinical trials we are supporting that allow Hawthorne Heroes to be truly on the front lines of transformational, lifesaving clinical research.Learn More